---
$id: https://graph.org.ai/products/commodity/51131705
$type: Product
source: UNSPSC
code: "51131705"
title: "Dipyridamole"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dipyridamole

**UNSPSC Code**: 51131705
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C24H40N8O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64ALC7F90C, chemically known as 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine but generally known as dipyridamole, which bears US NIH Compound Identifier 3108. European Medicines Agency schedules Dipyridamole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07229MIG. The term DIPYRIDAMOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules dipyridamole in its Anatomical Therapeutic Chemical (ATC) Classification. DIPYRIDAMOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dipyridamole under HS 29335995 and SITC 51576. As of Q4 2014, DIPYRIDAMOLE remains the US FDA Preferred Term for this commodity. Dipyridamole bears US NLM identifiers UMLS ID C0012582 and NCI Concept Code C445. SMILES: OCCN(C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO)CCO.

